Page last updated: 2024-09-04

cycloastragenol and Stomach Neoplasms

cycloastragenol has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, KS; Alharbi, SA; Chinnathambi, A; Hwang, ST; Kim, C; Lee, JH; Sethi, G; Shair, OHM	1

Other Studies

1 other study(ies) available for cycloastragenol and Stomach Neoplasms

Article	Year
Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 59 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 1; Janus Kinase 2; Paclitaxel; Phosphorylation; Phytotherapy; Sapogenins; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms	2019

Article

Year

Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 59

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 1; Janus Kinase 2; Paclitaxel; Phosphorylation; Phytotherapy; Sapogenins; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms

2019